Internal Medicine, Cardiovascular Disease · La Jolla, CA
NPI
1952358632
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
10820 N Torrey Pines Rd
La Jolla, CA, 92037
Phone (858) 554-3332
Groups this clinician bills Medicare through
Medicare paid, 2024
$334K
6,374 services
Medicare patients, 2024
2,913
Average age 76
Drug cost, 2024
$2.0M
7,601 prescriptions
Company payments, 2025
$2,045
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas W Triffon was code 99214 (office e&m - established), 1,326 times for 607 patients. In total Douglas W Triffon billed 6,374 services in 47 codes, and Medicare paid $334K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2009-06-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,326 | 607 | $97.72 | $130K |
| 93306 Echocardiography (TTE/TEE) | Office | 957 | 952 | $100.21 | $96K |
| 93798 Cardiac Rehabilitation | Office | 908 | 79 | $21.05 | $19K |
| 93010 Electrocardiogram | Office | 841 | 804 | $5.80 | $4,882 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 403 | 304 | $13.46 | $5,425 |
| 93356 Echocardiography (TTE/TEE) | Office | 382 | 381 | $31.67 | $12K |
| Q9957 Injection, perflutren lipid microspheres, per ml | Office | 378 | 188 | $32.73 | $12K |
| 93306 Echocardiography (TTE/TEE) | Facility | 137 | 136 | $53.74 | $7,363 |
| 93000 Electrocardiogram | Office | 97 | 95 | $12.00 | $1,164 |
| 93308 Echocardiography (TTE/TEE) | Office | 96 | 94 | $46.74 | $4,487 |
| 99213 Office E&M - Established | Office | 79 | 62 | $71.67 | $5,662 |
| 93325 Echocardiography (TTE/TEE) | Office | 68 | 67 | $11.50 | $782 |
| 93321 Echocardiography (TTE/TEE) | Office | 64 | 63 | $11.96 | $765 |
| 93228 Electrocardiogram | Office | 59 | 59 | $20.06 | $1,183 |
| 93356 Echocardiography (TTE/TEE) | Facility | 49 | 48 | $8.46 | $415 |
By year: 2022 $240K for 4,227 services; 2023 $280K for 4,900 services; 2024 $334K for 6,374 services.
Medicare prescription drug claims, 2024
In 2024, the drug Douglas W Triffon prescribed most often to Medicare patients was Ezetimibe, with 1,034 prescriptions and refills. In total Douglas W Triffon wrote 7,601 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ezetimibe Generic | 1,034 | 3,007 | 347 | $32K |
| Rosuvastatin Calcium Generic | 739 | 2,139 | 235 | $9,900 |
| Repatha Sureclick Evolocumab | 477 | 1,040 | 110 | $586K |
| Amlodipine Besylate Generic | 475 | 1,351 | 144 | $3,438 |
| Atorvastatin Calcium Generic | 306 | 898 | 98 | $3,363 |
| Losartan Potassium Generic | 286 | 829 | 91 | $2,831 |
| Eliquis Apixaban | 221 | 562 | 68 | $321K |
| Carvedilol Generic | 205 | 581 | 61 | $1,910 |
| Clopidogrel Clopidogrel Bisulfate | 200 | 599 | 63 | $3,558 |
| Praluent Pen Alirocumab | 189 | 474 | 52 | $245K |
| Metoprolol Succinate Generic | 172 | 472 | 52 | $2,993 |
| Eplerenone Generic | 139 | 364 | 44 | $14K |
| Potassium Chloride Generic | 132 | 347 | 40 | $3,167 |
| Lisinopril Generic | 130 | 332 | 39 | $852 |
| Irbesartan Generic | 117 | 317 | 32 | $2,553 |
Brand drugs: - claims; generic drugs: 6,036 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas W Triffon $2,045 ($2,045 in general payments such as food, travel and fees) from 14 companies. The largest payer was Regeneron Healthcare Solutions, Inc. with $485.
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. REGN | 25 | $485 |
| Chiesi USA, Inc. | 1 | $475 |
| Novartis Pharmaceuticals Corporation NVS | 12 | $246 |
| Pfizer Inc. PFE | 11 | $142 |
| Amgen Inc. AMGN | 8 | $142 |
| Esperion Therapeutics, Inc. ESPR | 11 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $117 |
| Alnylam Pharmaceuticals Inc. ALNY | 4 | $85.2 |
| Boston Scientific Corporation BSX | 4 | $82.34 |
| Edwards Lifesciences Corporation EW | 1 | $31.11 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.